ArticleFrontiers in cardiovascular medicine2026
Clinicopathological analysis of 124 cardiac tumors: a single-center retrospective study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize the clinicopathological features, pathological spectrum, and anatomical distribution of cardiac tumors and to evaluate the diagnostic challenges associated with these rare lesions. Methods: A retrospective analysis was performed on 124 surgically resected cardiac tumors diagnosed at the Affiliated Hospital of Zunyi Medical University between January 2012 and June 2026. Histological examination, immunohistochemistry, and fluorescence Results: Among the 124 cardiac tumors, myxoma constituted the predominant entity (104/124, 83.9%). A marked predilection for the left atrium was noted, with 78.8% of myxomas located there (82/104), significantly surpassing the frequency in the right atrium ( Conclusions: This single-center retrospective series highlights the diverse histopathological spectrum of cardiac tumors, affirming myxoma as the predominant tumor type with a strong left atrial predilection. Although rare, malignant tumors presented diagnostic challenges, necessitating multidisciplinary evaluation that integrates morphology, immunohistochemistry, and molecular testing. The observed age-related difference in the distribution of malignancy should be regarded as exploratory and requires further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.